John Hilton
Ottawa Hospital Research Institute · The Ottawa Hospital
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name John Hilton as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:03 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05601440 · Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast CancerCanadian Cancer Trials Group · recruiting · Breast Cancer · study chair
- Ph4NCT05365230 · A Randomized Trial Evaluating Personalized vs Guideline-based Well Follow-up Strategies for Patients With Early-stage Breast CancerOttawa Hospital Research Institute · completed · Breast Cancer · principal investigator
- Ph1NCT02719977 · A Phase I Study of CX5461Canadian Cancer Trials Group · completed · Cancer · study chair
- Ph4NCT02688803 · Multicentre Study to Determine the Feasibility of Using an Integrated Consent Model to Compare Three Standard of Care Regimens for The Treatment of Triple-Negative Breast Cancer in the Neoadjuvant/Adjuvant Setting (REaCT-TNBC)Ottawa Hospital Research Institute · terminated · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:03 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 1 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name in breast cancer, ranked by citations from NIH iCite, fetched 2026-11-12 11:03 UTC. The ranking covers the 200 most relevant of 25 PubMed records, and a shared surname and initials can bring in a namesake. All 25 on PubMed
- 214 citationsRCR 8.0
- A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients.Breast Cancer Res Treat · 201960 citationsRCR 2.5
- A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer.Eur J Cancer · 202159 citationsRCR 3.5
- A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229).Oncologist · 201953 citationsRCR 1.7
- Acquisition of metastatic tissue from patients with bone metastases from breast cancer.Breast Cancer Res Treat · 201150 citationsRCR 1.2
- 31 citationsRCR 1.5
- 31 citationsRCR 1.9
- A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.Breast Cancer Res Treat · 201423 citationsRCR 0.8
- A Phase I/II Study of GSK525762 Combined with Fulvestrant in Patients with Hormone Receptor-positive/HER2-negative Advanced or Metastatic Breast Cancer.Clin Cancer Res · 202417 citationsRCR 1.9
- 15 citationsRCR 3.2